Market News

Interocean Capital Trimmed By $347,778 Its Johnson & Johnson (JNJ) Position; CANNABIX TECHNOLOGIES ORDINARY SHAR (BLOZF) Shorts Up By 16.5%

Cannabix Technologies Inc. (OTCMKTS:BLOZF) Logo

CANNABIX TECHNOLOGIES INC ORDINARY SHAR (OTCMKTS:BLOZF) had an increase of 16.5% in short interest. BLOZF’s SI was 216,000 shares in April as released by FINRA. Its up 16.5% from 185,400 shares previously. With 274,600 avg volume, 1 days are for CANNABIX TECHNOLOGIES INC ORDINARY SHAR (OTCMKTS:BLOZF)’s short sellers to cover BLOZF’s short positions. The SI to CANNABIX TECHNOLOGIES INC ORDINARY SHAR’s float is 0.27%. The stock decreased 0.41% or $0.0058 during the last trading session, reaching $1.4182. About 22,600 shares traded. Cannabix Technologies Inc. (OTCMKTS:BLOZF) has 0.00% since April 26, 2017 and is . It has underperformed by 11.55% the S&P500.

Interocean Capital Llc decreased Johnson & Johnson (JNJ) stake by 1.46% reported in 2017Q4 SEC filing. Interocean Capital Llc sold 2,502 shares as Johnson & Johnson (JNJ)’s stock declined 9.21%. The Interocean Capital Llc holds 168,996 shares with $23.61 million value, down from 171,498 last quarter. Johnson & Johnson now has $344.26 billion valuation. The stock increased 1.24% or $1.57 during the last trading session, reaching $128.33. About 4.34 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since April 26, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

Investors sentiment increased to 0.87 in Q4 2017. Its up 0.04, from 0.83 in 2017Q3. It is positive, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. Solaris Asset Management Ltd Liability Co has invested 0.13% in Johnson & Johnson (NYSE:JNJ). Putnam Fl Mngmt reported 38,579 shares. Pittenger & Anderson Inc holds 54,310 shares or 0.66% of its portfolio. Parsons Capital Management Ri stated it has 134,653 shares or 2.1% of all its holdings. Fidelity Fin has 58,480 shares. Blb&B Advsrs Limited Liability holds 2.54% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 127,090 shares. Dekabank Deutsche Girozentrale holds 1.69% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 1.62M shares. Ohio-based Diamond Hill Mngmt Inc has invested 0% in Johnson & Johnson (NYSE:JNJ). 22,490 were reported by Natl Registered Inv Advisor. Windward Mgmt Ca owns 93,768 shares. Wade G W And holds 145,784 shares or 2.34% of its portfolio. Moneta Gp Invest Advsrs Ltd stated it has 20,478 shares. Washington Tru Co holds 0.9% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 114,256 shares. Counsel Limited Com has invested 5.08% of its portfolio in Johnson & Johnson (NYSE:JNJ). Rowland And Invest Counsel Adv stated it has 3.89% of its portfolio in Johnson & Johnson (NYSE:JNJ).

Since February 15, 2018, it had 0 insider purchases, and 1 insider sale for $20.17 million activity. 155,342 Johnson & Johnson (NYSE:JNJ) shares with value of $20.17M were sold by Stoffels Paulus.

Interocean Capital Llc increased Alps Alerian Mlp Etf (AMLP) stake by 155,525 shares to 1.56 million valued at $16.87 million in 2017Q4. It also upped Technology Select Sector Spdr (XLK) stake by 17,363 shares and now owns 73,917 shares. Bayer A G Sponsored Adrf Spons was raised too.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 100 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus on Wednesday, January 24 with “Hold”. The stock of Johnson & Johnson (NYSE:JNJ) earned “Overweight” rating by Barclays Capital on Wednesday, April 20. RBC Capital Markets maintained it with “Buy” rating and $13800 target in Monday, July 10 report. The firm earned “Buy” rating on Tuesday, January 16 by Jefferies. Jefferies maintained the shares of JNJ in report on Friday, April 13 with “Buy” rating. The firm has “Buy” rating by RBC Capital Markets given on Wednesday, October 18. UBS maintained the stock with “Buy” rating in Wednesday, July 19 report. On Friday, March 23 the stock rating was maintained by Jefferies with “Buy”. As per Wednesday, October 7, the company rating was maintained by RBC Capital Markets. The firm has “Buy” rating by RBC Capital Markets given on Sunday, August 27.

Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the work place in North America. The company has market cap of $138.38 million. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. It currently has negative earnings. The firm was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *